Dr. Lekshmi r.Nath – Non alcoholic fatty liver -hepatocellular carcinoma – Women Researcher Award

Dr. Lekshmi r.Nath - Non alcoholic fatty liver -hepatocellular carcinoma - Women Researcher Award

Amrita Vishwa vidyapeetham - India

Author Profile 

SCOPUS

ORCID

Early academic pursuits 🎓

Dr. Lekshmi r.Nath embarked on her academic journey in pharmaceutical sciences with a b.pharm degree from mahatma gandhi university, india. her passion for natural products and their medicinal properties led her to pursue an m.pharm in pharmacognosy from rajiv gandhi university of health sciences. she further specialized in biotechnology, earning her ph.d. from the rajiv gandhi centre for biotechnology, kerala, where her research focused on evaluating the anticancer effects of active principles from solanum nigrum linn and chromolaena odorata.

Professional endeavors 🏢

currently an associate professor in the department of pharmacognosy at the amrita school of pharmacy, dr. lekshmi has established herself as a dedicated educator and researcher. her professional journey is marked by her contributions to the field of pharmacognosy, particularly in the exploration of natural products for therapeutic applications. her teaching and mentorship have influenced many students and researchers in the field of pharmaceutical sciences.

Contributions and research focus 🔬

dr. lekshmi's research is centered on the discovery and development of natural products with therapeutic potential. her ph.d. research led to the identification of uttroside b, a compound with significant anticancer properties, particularly against hepatocellular carcinoma. her work extends Non alcoholic fatty liver -hepatocellular carcinoma to both in vitro and in vivo studies, providing a strong foundation for the therapeutic application of natural products. her innovative approach to pharmacognosy continues to contribute valuable insights into the field.

Accolades and recognition 🏅

dr. lekshmi's research has been recognized globally, particularly her work on uttroside b, which has received both u.s. and canadian patents. the significance of her findings was further acknowledged when the fda granted orphan drug designation to uttroside b for the treatment of Non alcoholic fatty liver -hepatocellular carcinoma hepatocellular carcinoma. these accolades underscore her impact in the field of cancer research and her contribution to the development of novel therapeutics.

Impact and influence 🌍

through her research, dr. lekshmi has made a profound impact on the field of pharmacognosy and cancer therapeutics. her discovery of Non alcoholic fatty liver -hepatocellular carcinoma uttroside b offers a new avenue for the treatment of hepatocellular carcinoma, potentially improving outcomes for patients with this challenging disease. her work not only advances scientific knowledge but also has the potential to make a tangible difference in the lives of those affected by cancer.

Legacy and future contributions 🔮

dr. lekshmi's legacy is rooted in her pioneering research on natural products and their application in cancer therapy. her work on uttroside b sets the stage for future research and development in the field, with the potential to lead to new treatments for cancer. as she continues her work, dr. lekshmi is poised to make further contributions to the understanding and use of natural products in medicine, inspiring future generations of researchers.

Notable Publications

Prof Dr. Phunchai Charatcharoenwitthaya – Gastroenterology and Hepatology – Best Researcher Award

Prof Dr. Phunchai Charatcharoenwitthaya - Gastroenterology and Hepatology - Best Researcher Award

Division of Gastroenterology - Thailand

Professional Profile

SCOPUS

EARLY ACADEMIC PURSUITS 🎓

Phunchai Charatcharoenwitthaya embarked on his medical journey with an MD in 1993, followed by a Diplomate in Internal Medicine in 1999 and Gastroenterology in 2001. His commitment to advancing his expertise led him to earn an MSc in Biomedical Sciences in 2007. His foundational years were marked by rigorous training and academic excellence, culminating in a research fellowship at the prestigious Mayo Clinic in Rochester, USA. These early academic endeavors laid a strong groundwork for his future contributions to the field of gastroenterology and hepatology.

PROFESSIONAL ENDEAVORS 🏥

As a Professor of Medicine at the Faculty of Medicine, Siriraj Hospital, Mahidol University, Thailand, Phunchai has held several key positions that reflect his leadership and dedication to medical science. He has played pivotal roles in the Gastroenterological Association of Thailand and currently serves as the President Elect of the Thai Association for the Study of the Liver. His professional journey is characterized by a blend of clinical excellence, administrative leadership, and a commitment to advancing medical education and research.

CONTRIBUTIONS AND RESEARCH FOCUS 🔬

Phunchai's research primarily focuses on metabolic dysfunction-associated steatotic disease (MASLD), chronic liver diseases, and cirrhosis with complications. His prolific contributions include over 120 peer-reviewed publications that have significantly advanced diagnostic methods and Gastroenterology and Hepatology treatment protocols. His pioneering studies on the epidemiology of MASLD in non-obese populations and the identification of key metabolic phenotypes influencing disease progression have been particularly impactful. His research efforts have not only enhanced scientific understanding but also improved patient care and clinical practices globally.

ACCREDITATIONS AND RECOGNITION 🏅

Phunchai's work has been widely recognized and cited, with an H-index of 25 and 6753 citations by 5,986 documents in Scopus. He has published 124 articles in indexed journals and authored four international books with ISBN numbers. His editorial roles as Associate Editor for three journals and on the editorial boards of two others underscore his influence and standing in the scientific community. His accolades include Gastroenterology and Hepatology multiple awards and recognitions from esteemed medical and research organizations, highlighting his contributions to gastroenterology and hepatology.

IMPACT AND INFLUENCE 🌟

Phunchai's research has had a profound impact on clinical practices and guidelines, particularly in the management of MASLD and chronic liver diseases. His collaborative work with the GO-ASIA research group and the international NAFLD research group has led to significant Gastroenterology and Hepatology advancements in understanding and treating these conditions. His contributions have been instrumental in shaping contemporary medical approaches, improving diagnostic accuracy, and enhancing treatment outcomes for patients worldwide.

LEGACY AND FUTURE CONTRIBUTIONS 🔮

Phunchai Charatcharoenwitthaya's legacy is defined by his relentless pursuit of knowledge, his dedication to improving patient care, and his influential research contributions. His ongoing projects and collaborations promise to continue advancing the field of hepatology. As he moves forward, his work is expected to further unravel the complexities of metabolic-associated steatotic liver disease and chronic liver conditions, ensuring his lasting impact on medical science and patient health.

NOTABLE PUBLICATIONS